Jefferies⬆️the PT on $ATYR to $17 from $9, reiterated at Buy and Provided its Base (plus 1-3X), Bull (plus 3-5X) and Bear (up to -75%+) Case Scenarios ahead of mid-Sept Efzofitimod Ph3 topline data.
aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) - GlobeNewswire https://t.co/pmXwbf2sBJ
U.S. companies created 183,000 jobs last month, according to the ADP's monthly data. That was slightly more than the upwardly revised 176,000 in December and much more than the 150,000 economists were expecting
H.C. Wainwright reit $ATYR Buy/$35, after the Foundation for Sarcoidosis Res hosted a Patient-Focused Drug Development meeting as a forum4sarcoidosis pts, caregivers/Tx'g MD's 2 discuss current unmet needs, the QoL impacts of sarcoidosis/preferences w/ respect2 devt of new Tx's:
Un desarrollador de Bitcoin argumenta que cualquier cambio en el suministro fijo de Bitcoin, aunque teóricamente posible, ya no se consideraría "Bitcoin".
Fuente: Cointelegraph https://t.co/WpPyv9Ni1N